For patients diagnosed with EL, TRAT1, a T cell-specific gene, could be a promising treatment avenue as this gene was found to be uniquely expressed and significantly upregulated in this disorder, which makes sense given the tumor is T cell-derived (11). This evidence concerns the gene TRAT1 and neoplasm.